Avoro Capital Advisors LLC Tango Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$2.93 - $11.26 $1.71 Million - $6.56 Million
582,222 Added 35.5%
2,222,222 $25 Million
Q4 2022

Feb 14, 2023
BUY
$3.41 - $8.29 $306,900 - $746,099
90,000 Added 5.81%
1,640,000 $11.9 Million
Q3 2021

Nov 15, 2021
BUY
$9.56 - $17.3 $14.8 Million - $26.8 Million
1,550,000 New
1,550,000 $20 Million

Others Institutions Holding TNGX

# of Institutions
123
Shares Held
91.7M
Call Options Held
3.1K
Put Options Held
1.5K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $359M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email